Back
Bel Fuse Vs. Keros Therapeutics Industry Stock Comparison
Buy
87
BELFB
Bel Fuse
Last Price:
$126.74
Seasonality Move:
6.2%
Sell
27
KROS
Keros Therapeutics
Last Price:
$14.51
Seasonality Move:
25.73%
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $14.46. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $14.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
BELFB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 78.64 | Buy |
Chaikin Money Flow: | 225880 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (94 - 105.8) | Buy |
Bollinger Bands (100): | (68.04 - 93.2) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.15 | Buy |
Relative Strength Index (14 RSI): | 57.87 | Buy |
Chaikin Money Flow: | 12030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.49 - 14.35) | Buy |
Bollinger Bands (100): | (11.71 - 14.63) | Buy |
BELFB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.17 | Buy |
20-day SMA: | 101.78 | Buy |
50-day SMA: | 88.78 | Buy |
200-day SMA: | 80.82 | Buy |
8-day EMA: | 106.9 | Buy |
20-day EMA: | 101.43 | Buy |
50-day EMA: | 92.25 | Buy |
200-day EMA: | 80.3 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.17 | Buy |
20-day SMA: | 13.99 | Buy |
50-day SMA: | 14.04 | Buy |
200-day SMA: | 24.35 | Sell |
8-day EMA: | 3.21 | Buy |
20-day EMA: | 1.38 | Buy |
50-day EMA: | 0.57 | Buy |
200-day EMA: | 0.14 | Buy |
Bel Fuse Earnings Growth & BELFB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.21 per share, an increase this year of $0.87 per share, and an increase next year of $0.67 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Bel Fuse Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |